Literature DB >> 639180

Converting enzyme inhibitor and saralasin infusion in rats. Evidence for an additional vasodepressor property of converting enzyme inhibitor.

H Thurston, J D Swales.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 639180     DOI: 10.1161/01.res.42.5.588

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  15 in total

Review 1.  Hypertension.

Authors:  G W Ching; D G Beevers
Journal:  Postgrad Med J       Date:  1991-03       Impact factor: 2.401

Review 2.  Circulating and tissue angiotensin systems.

Authors:  D J Campbell
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

3.  The effect of enalapril (MK421), an angiotensin converting enzyme inhibitor, on the conscious pregnant ewe and her foetus.

Authors:  F Broughton Pipkin; C P Wallace
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

4.  Amyloid-containing renal interstitial cell nodules (RICNs) associated with chronic arterial hypertension in older age groups.

Authors:  A Zimmermann; P Luscieti; B Flury; M W Hess; H Cottier
Journal:  Am J Pathol       Date:  1981-12       Impact factor: 4.307

Review 5.  Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?

Authors:  M P Sambhi; H Gavras; J I Robertson; W M Smith
Journal:  West J Med       Date:  1993-03

Review 6.  Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney.

Authors:  G P Reams; J H Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

7.  Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive rats.

Authors:  B Chauvin; C Richer; J F Giudicelli
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

8.  Effect of converting enzyme inhibition on the renal haemodynamic responses to noradrenaline infusion in the rat.

Authors:  L A Arundell; E J Johns
Journal:  Br J Pharmacol       Date:  1982-03       Impact factor: 8.739

9.  Hormonal and blood pressure changes during converting enzyme inhibition by teprotide.

Authors:  M J VandenBurg; V L Sharman; J J Morton; G H Williams; F P Marsh
Journal:  Postgrad Med J       Date:  1981-05       Impact factor: 2.401

10.  Effects of bradykinin B2 receptor antagonism on the hypotensive effects of ACE inhibition.

Authors:  H Bouaziz; Y Joulin; M Safar; A Benetos
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.